Cargando…
Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture
BACKGROUND: Positive anticyclic citrullinated peptide (anti-CCP+) is associated with bone loss in patients with rheumatoid arthritis (RA). However, whether overall positivity or specific levels of anti-CCP are associated with prevalent fracture or a 10-year probability of fracture remains unclear. M...
Autores principales: | Cheng, Tien-Tsai, Yu, Shan-Fu, Su, Fu-Mei, Chen, Yin-Chou, Su, Ben Yu-Jih, Chiu, Wen-Chan, Hsu, Chung-Yuan, Chen, Jia-Feng, Ko, Chi-Hua, Lai, Han-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791167/ https://www.ncbi.nlm.nih.gov/pubmed/29382355 http://dx.doi.org/10.1186/s13075-018-1515-1 |
Ejemplares similares
-
FRAX-based fracture probabilities in South Africa
por: Johansson, Helena, et al.
Publicado: (2021) -
The Influence of Polygenic Risk Scores on Heritability of Anti-CCP Level in RA
por: Cui, Jing, et al.
Publicado: (2014) -
Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey
por: Yu, Shan-Fu, et al.
Publicado: (2017) -
FRAX™ and the assessment of fracture probability in men and women from the UK
por: Kanis, J. A., et al.
Publicado: (2008) -
Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment
por: Ye, Carrie, et al.
Publicado: (2023)